Case report: Pediatric patients with COVID-19 presented as multi-system inflammatory syndrome
COVID-19 in pediatric patients is typically associated with minimal manifestations and is less severe than adult patients. Recently, there are reports of children with COVID 19 and myocardial involvement from Europe and America that first were assumed to be Kawasaki disease or its atypical presentation. However world health organization has set a new designation for this state; “multi-system involvement syndrome” in children with COVID-19; (MIS-C).
Here we report two COVID-19 pediatric patients (two girls aged 10 and 13 years old) with MIS-C.
Presence of Kawasaki like signs in COVID 19 patients should be an alarming point to consider multi-system inflammatory syndrome; a syndrome with extensive organ involvement and yet indistinct exact pathophysiology.
Figure 1
Figure 2
Figure 3
Posted 10 Jun, 2020
Case report: Pediatric patients with COVID-19 presented as multi-system inflammatory syndrome
Posted 10 Jun, 2020
COVID-19 in pediatric patients is typically associated with minimal manifestations and is less severe than adult patients. Recently, there are reports of children with COVID 19 and myocardial involvement from Europe and America that first were assumed to be Kawasaki disease or its atypical presentation. However world health organization has set a new designation for this state; “multi-system involvement syndrome” in children with COVID-19; (MIS-C).
Here we report two COVID-19 pediatric patients (two girls aged 10 and 13 years old) with MIS-C.
Presence of Kawasaki like signs in COVID 19 patients should be an alarming point to consider multi-system inflammatory syndrome; a syndrome with extensive organ involvement and yet indistinct exact pathophysiology.
Figure 1
Figure 2
Figure 3